Related Experiment Video
Updated: May 15, 2026
11:28
Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
Published on: April 28, 2015
Development of gadolinium based nanoparticles having an affinity towards melanin
Jessica Morlieras1, Jean-Michel Chezal, Elisabeth Miot-Noirault
1Laboratoire de Physico-Chimie des Matériaux Luminescents, UMR 5620 CNRS - Université Claude Bernard Lyon 1, Université de Lyon, 69622 Villeurbanne Cedex, France.
Nanoscale
|January 22, 2013
Summary
Researchers developed novel gadolinium-based Small Rigid Platforms (SRPs) for cancer imaging. These nanoparticles show promising affinity for melanin, a key target in melanoma, paving the way for advanced theranostics.
Area of Science:
- Nanotechnology
- Materials Science
- Biomedical Engineering
Background:
- Small Rigid Platforms (SRPs) are gadolinium-based nanoparticles (<5 nm) designed for multimodal imaging and theranostics.
- They feature a polysiloxane core with surrounding gadolinium chelates.
Purpose of the Study:
- To functionalize SRPs with quinoxaline derivatives for enhanced melanoma targeting.
- To investigate the in vitro affinity of these modified nanoparticles for melanin.
Main Methods:
- Synthesis and covalent coupling of three distinct quinoxaline derivatives to SRPs.
- In vitro evaluation of nanoparticle-melanin affinity using surface plasmon resonance (SPR) on a custom melanin-coated gold chip.
Main Results:
- Successful grafting of quinoxaline derivatives onto the Small Rigid Platforms.
- Demonstrated in vitro affinity of the functionalized SRPs for melanin via SPR analysis.
Conclusions:
- Quinoxaline-functionalized SRPs exhibit specific binding to melanin.
- These nanoparticles hold potential for targeted melanoma imaging and therapy.
